Tower Research Capital LLC (TRC) - X4 PHARMACEUTICALS INC ownership

X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 94 filers reported holding X4 PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 2.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of X4 PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$15,639
-30.6%
26,963
+66.3%
0.00%
-100.0%
Q1 2024$22,531
+117.7%
16,209
+31.4%
0.00%
Q4 2023$10,351
-7.6%
12,338
+20.1%
0.00%
Q3 2023$11,202
-0.8%
10,277
+76.6%
0.00%
Q2 2023$11,293
+1129200.0%
5,821
+618.6%
0.00%
Q1 2023$1
-90.0%
810
-92.1%
0.00%
Q4 2022$10
-99.8%
10,227
+81.4%
0.00%
Q2 2022$5,000
-68.8%
5,639
-41.8%
0.00%
Q1 2022$16,000
+128.6%
9,695
+675.6%
0.00%
Q3 2021$7,000
-91.9%
1,250
-90.6%
0.00%
-100.0%
Q2 2021$86,000
+230.8%
13,231
+337.7%
0.00%
Q1 2021$26,000
-33.3%
3,023
-50.6%
0.00%
-100.0%
Q4 2020$39,000
-67.2%
6,124
-65.2%
0.00%0.0%
Q3 2020$119,000
+310.3%
17,588
+470.7%
0.00%0.0%
Q2 2020$29,000
-3.3%
3,082
+54.6%
0.00%
-50.0%
Q2 2019$30,000
+275.0%
1,994
+343.1%
0.00%
Q1 2019$8,0004500.00%
Other shareholders
X4 PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
CVI Holdings, LLC 2,300,315$4,462,6114.69%
Stonepine Capital Management, LLC 4,605,263$8,934,2103.22%
Bain Capital Life Sciences Investors, LLC 15,960,588$30,963,5413.19%
Tri Locum Partners LP 4,099,943$7,953,8892.96%
NEA Management Company, LLC 14,986,793$29,074,3782.22%
Lynwood Capital Management Inc. 525,000$1,018,5001.29%
Parkman Healthcare Partners LLC 3,766,593$7,307,1901.27%
Sio Capital Management, LLC 1,749,003$3,393,0660.86%
New Leaf Venture Partners, L.L.C. 335,000$649,9000.56%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,973,683$3,828,9450.36%
View complete list of X4 PHARMACEUTICALS INC shareholders